http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6425720-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1755eede76ea7e719a3e0d2843cd793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 |
| filingDate | 1988-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b9610e23a44e5cf3299f601a80dcb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d7632057c5d3da97d1b945d407aa2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cfe3dbec5e5282e8de6b70b5ab24ea5 |
| publicationDate | 1989-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S6425720-A |
| titleOfInvention | Percutaneous absorption pharmaceutical |
| abstract | PURPOSE:To obtain a percutaneous absorption pharmaceutical, by using a specific absorbefacient consisting of combination of a fatty acid ester with a specific N-acylsarcosine, etc., and capable of improving percutaneous absorbability and stability of nicorandils useful as a remedy for angina pectoris. CONSTITUTION:A percutaneous absorption pharmaceutical, obtained by blending nicorandil useful as the above-mentioned medicine and/or salts thereof with an absorbefacient consisting of combination of (A) a fatty acid ester, preferably an ester synthesized from a 10-18C fatty acid and a 1-20C alcohol, especially isopropyl myristate, etc., with (B) an N-acylsarcosine, fatty acid mono- or diethanolamides or alkylene oxide adducts thereof, preferably N-lauroylsarcosine, lauroylmono- or diethanolamide, etc., in a base and having excellent absorbability and stability of the aforementioned medicine. |
| priorityDate | 1987-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.